BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT06568939-completion@plaintrial.com
DTSTAMP:20261030T140338Z
DTSTART;VALUE=DATE:202802
SUMMARY:A Study to Assess Adverse Events and How Intravenously (IV) Infused
  Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy 
 in Adult Participants With Previously Treated Non-Squamous Non-Small Cell 
 Lung Cancer (NSCLC) — estimated completion date
DESCRIPTION:Recruiting. Saved on your PlainTrial shortlist. Full trial reco
 rd: https://plaintrial.com/trial/NCT06568939
URL:https://plaintrial.com/trial/NCT06568939
END:VEVENT
END:VCALENDAR